• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON, DICKINSON & CO. (SPARKS) BD BBL¿ MGIT¿ MYCOBACTERIA GROWTH INDICATOR TUBES, 7ML; SYSTEM, BLOOD CULTURING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON, DICKINSON & CO. (SPARKS) BD BBL¿ MGIT¿ MYCOBACTERIA GROWTH INDICATOR TUBES, 7ML; SYSTEM, BLOOD CULTURING Back to Search Results
Catalog Number 245122
Device Problems Incorrect, Inadequate or Imprecise Result or Readings (1535); Contamination of Device Ingredient or Reagent (2901)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 11/21/2023
Event Type  malfunction  
Event Description
It was reported when using the bd bbl¿ mgit¿ mycobacteria growth indicator tubes, 7ml customer noticed a white haze, and it grew a gram staining revealed gram-negative bacilli.There was no report of impact to patient or user.
 
Manufacturer Narrative
H.3.A device evaluation is anticipated, but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.
 
Manufacturer Narrative
The following fields were updated due to corrected information: e.1.Initial reporter first name: (b)(6) h.6 imdrf annex a grid: a0908 - incorrect, inadequate or imprecise result or readings d9: device available for evaluation: yes, d.9:device eval by manufacturer? yes, d9: returned to manufacturer on: 15-apr-2024.H.6 investigation summary material 245122 is manufactured by rehydrating the media components with usp purified water, and thoroughly mixing until a homogeneous solution is obtained.The tubes are filled, capped, torqued and then labeled by machine per standard operating procedure (sop).The tubes are terminally autoclaved in an air over pressure (aop) autoclave, per manufacturing instructions, using a validated cycle.Post autoclaving, tubes are packaged into final shipping configurations.As part of the release criteria for this product, the bhr is reviewed to confirm the following: the total elapsed time between end of formulation and start of the autoclave cycle was within the specified limits.All autoclave parameters conformed to the validated cycle parameters for this product.The minimum f0 for this product was met.The complaint history was reviewed, and there are three complaints for contamination.Retention samples from batch 3103482 (100 tubes) were available for inspection.There were 39/100 tubes found with a white spot in the bottom of the tube.For investigation, retention tubes were divided and incubated at 20-25 degrees celsius (19 tubes) and 30-35 degrees celsius (20 tubes).No growth was observed at 14 days incubation.When the tubes with the white spots were shaken, the spot dispersed into particles in solution.Eight photos were submitted for investigation of this complaint.Two photos showed the carton, batch 3103482.One photo showed an open carton with the tube caps visible.Five photos showed a white ring around the tube below the bottom of the tube label.There were 200 tubes returned to assist in the investigation of this complaint.Two 100 pack cartons were received in a box with bubble wrap and air bubbles.One hundred tubes were incubated in a 20 to 25 degree celsius incubator.One hundred returned tubes were incubated in a 33 to 37 degree celsius incubator.At 14 days, there was no growth in any of the tubes.There were no defects noticed in the returned tubes.This complaint can be confirmed for particles from the retention samples.This product is not labeled as sterile.Media should be inspected prior to use and should not be used if medium shows evidence of contamination, drying, cracking or other signs of deterioration.No complaint trends for this complaint have been identified for this product; no actions are indicated at this time.Bd will continue to trend complaints for contamination.
 
Event Description
It was reported when using the bd bbl¿ mgit¿ mycobacteria growth indicator tubes, 7ml customer noticed a white haze, and it grew a gram staining revealed gram-negative bacilli.There was no report of impact to patient or user.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD BBL¿ MGIT¿ MYCOBACTERIA GROWTH INDICATOR TUBES, 7ML
Type of Device
SYSTEM, BLOOD CULTURING
Manufacturer (Section D)
BECTON, DICKINSON & CO. (SPARKS)
7 loveton circle
sparks MD 21152
Manufacturer (Section G)
BECTON, DICKINSON & CO. (SPARKS)
7 loveton circle
sparks MD 21152
Manufacturer Contact
jo doyka
7 loveton circle
sparks, MD 21152
4103164000
MDR Report Key18330541
MDR Text Key330935410
Report Number1119779-2023-01370
Device Sequence Number1
Product Code MDB
UDI-Device Identifier30382902451229
UDI-Public(01)30382902451229
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
K974883
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 05/07/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Other
Device Catalogue Number245122
Device Lot Number3103482
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 11/21/2023
Initial Date FDA Received12/14/2023
Supplement Dates Manufacturer Received05/07/2024
Supplement Dates FDA Received05/24/2024
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured04/13/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-